Krascendo 1

Advertisement

cGxPJobs Banner

Roche’s Divarasib Beats Approved KRAS Therapies in Phase III Trial

Basel, Switzerland, July 2, 2026 Roche has announced positive top-line results from its pivotal Phase III Krascendo 1 clinical...

By cGxPwire Editor
July 3, 2026

Read More

Advertisement

cGxPJobs

Directory